Medicare demo emerges as coverage option for Alzheimer’s drug ...Middle East

News by : (Roll Call) -
The decision on how to cover an expensive and controversial new Alzheimer’s drug could be settled by letting Medicare run its own trial to study payment and treatment implications. Aduhelm, from drugmakers Biogen and Eisai, won accelerated approval from the Food and Drug Administration earlier this month despite objections from the agency’s advisory committee. While clinical trials […] The post Medicare demo emerges as coverage option for Alzheimer’s drug appeared first on Roll Call.

Read More Details
Finally We wish PressBee provided you with enough information of ( Medicare demo emerges as coverage option for Alzheimer’s drug )

Also on site :

Most Viewed News
جديد الاخبار